TARGET COMPLEX AS AN AGENT FOR INHIBITING TUMOUR CELLS AND FOR STIMULATING ANGIOGENESIS

Details for Australian Patent Application No. 2002252950 (hide)

Owner UNIVERSITATSKLINIKUM CHARITE MEDIZINISCHE FAKULTAT DER HUMBOLDT-UNIVERSITAT ZU BERLIN

Inventors PREIssNER, Robert; DUBIELL, Wolfgang; GOEDE, Andrean; FROMMEL, Cornelius

Pub. Number AU-A-2002252950

PCT Pub. Number WO2002/066021

Priority 101 09 883.9 22.02.01 DE; 101 17 266.4 30.03.01 DE

Filing date 21 February 2002

Wipo publication date 4 September 2002

International Classifications

A61K 031/05

A61K 031/12 - Ketones

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-A-2002252950

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252951-NUCLEIC ACIDS CODING FOR A PROTEIN INTERACTING WITH A PORIN CHANNEL

2002252949-2-(Alpha-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE